DK1076561T3 - Kombinationsterapi til behandlingen af tumorer - Google Patents

Kombinationsterapi til behandlingen af tumorer

Info

Publication number
DK1076561T3
DK1076561T3 DK99921972T DK99921972T DK1076561T3 DK 1076561 T3 DK1076561 T3 DK 1076561T3 DK 99921972 T DK99921972 T DK 99921972T DK 99921972 T DK99921972 T DK 99921972T DK 1076561 T3 DK1076561 T3 DK 1076561T3
Authority
DK
Denmark
Prior art keywords
combination therapy
tumors
treatment
gastrin
combination
Prior art date
Application number
DK99921972T
Other languages
Danish (da)
English (en)
Inventor
Philip C Gevas
Stephen Grimes
Dov Michaeli
Stephen L Karr
Susan A Watson
Original Assignee
Aphton Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphton Corp filed Critical Aphton Corp
Application granted granted Critical
Publication of DK1076561T3 publication Critical patent/DK1076561T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99921972T 1998-05-15 1999-05-14 Kombinationsterapi til behandlingen af tumorer DK1076561T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8568798P 1998-05-15 1998-05-15
PCT/US1999/010750 WO1999059628A2 (fr) 1998-05-15 1999-05-14 Therapie combinee pour le traitement de tumeurs

Publications (1)

Publication Number Publication Date
DK1076561T3 true DK1076561T3 (da) 2005-06-06

Family

ID=22193286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99921972T DK1076561T3 (da) 1998-05-15 1999-05-14 Kombinationsterapi til behandlingen af tumorer

Country Status (16)

Country Link
EP (1) EP1076561B1 (fr)
JP (1) JP2002515457A (fr)
KR (1) KR100699574B1 (fr)
CN (1) CN1216605C (fr)
AT (1) ATE291918T1 (fr)
AU (1) AU745749B2 (fr)
CA (1) CA2327439C (fr)
DE (1) DE69924483T2 (fr)
DK (1) DK1076561T3 (fr)
ES (1) ES2237103T3 (fr)
HK (1) HK1032360A1 (fr)
HU (1) HUP0101947A3 (fr)
PL (1) PL193109B1 (fr)
PT (1) PT1076561E (fr)
WO (1) WO1999059628A2 (fr)
ZA (1) ZA200005962B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508838A (ja) * 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
KR20040049830A (ko) * 2001-07-09 2004-06-12 애프톤 코포레이션 간, 폐 및 식도의 암 및 전암 상태의 치료 및 예방
AU2003267984A1 (en) * 2002-07-03 2004-01-23 Receptor Biologix, Inc. Liposomal vaccine
US7235376B2 (en) 2003-03-28 2007-06-26 Receptor Biologix, Inc. Gastrin hormone immunoassays
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US8674064B2 (en) 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
CN101797382B (zh) * 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
EA201100464A1 (ru) * 2011-04-06 2012-10-30 Ооо "Метамакс" (Ооо "Метамах") Фармацевтическая композиция для лечения гиперпролиферативных заболеваний и её применение
CN106163527A (zh) 2013-11-22 2016-11-23 Cl生物科技有限责任公司 用于治疗和预防骨质疏松症的胃泌素拮抗剂
JP7469225B2 (ja) 2017-06-15 2024-04-16 キャンサー アドヴァンシーズ インク． 腫瘍及び癌に対する体液性及び細胞性免疫を誘発するための組成物及び方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (fr) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Traitement par immunotherapie d'une tumeur, faisant appel a des anticorps monoclonaux de l'antigene 17-1a
ATE114160T1 (de) * 1989-01-24 1994-12-15 Aphton Corp Immunogenische zusammensetzungen gegen gastrin- peptide.
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17

Also Published As

Publication number Publication date
PL344414A1 (en) 2001-11-05
HUP0101947A3 (en) 2001-12-28
WO1999059628A2 (fr) 1999-11-25
PT1076561E (pt) 2005-08-31
CN1216605C (zh) 2005-08-31
PL193109B1 (pl) 2007-01-31
ES2237103T3 (es) 2005-07-16
DE69924483T2 (de) 2006-02-09
CN1303288A (zh) 2001-07-11
KR100699574B1 (ko) 2007-03-23
AU3904599A (en) 1999-12-06
EP1076561A2 (fr) 2001-02-21
AU745749B2 (en) 2002-03-28
CA2327439C (fr) 2005-07-05
KR20010052355A (ko) 2001-06-25
HK1032360A1 (en) 2001-07-20
DE69924483D1 (de) 2005-05-04
ATE291918T1 (de) 2005-04-15
WO1999059628A3 (fr) 2000-01-13
ZA200005962B (en) 2002-01-24
CA2327439A1 (fr) 1999-11-25
EP1076561B1 (fr) 2005-03-30
JP2002515457A (ja) 2002-05-28
HUP0101947A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
CY2473B1 (en) New phenanthridines.
EA200000994A1 (ru) Применение кабэрголина при лечении синдрома усталых ног
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
BG100517A (en) Combination of bisphosphonates and growth hormone secretagogues
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
MD1616F2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
CY2431B1 (en) Novel phenanthridines substituted in the 6 position.
SE9404196D0 (sv) New antithrombotic formulation
UA41355C2 (uk) Засіб для лікування нейро-сніду
GR3022321T3 (en) Use of il-4 to treat solid tumors
DK1076561T3 (da) Kombinationsterapi til behandlingen af tumorer
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE69316013T2 (de) Verwendung von phosphinate zur behandlung der osteoporose
SE9603725D0 (sv) New teatment
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
PH30665A (en) Aminosulfonyl urea acat inhibitors
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
MXPA01007952A (es) Formulaciones a base de l-arginina para tratar enfermedades, y metodos para usarlas.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.